The Vanguard Group, Inc. recently announced the acquisition of new stake in Gelesis Holdings Inc. (NYSE:GLS). The institutional investor has increased its shareholding in the Healthcare company by 584.67% to 2.92 million shares with purchase of 2.49 million shares. This fresh investment now brings its stake to 3.99% valued currently at $0.85 million. In addition, DNCA Finance SA raised its holdings by 1.3 million to 1.3 million shares. And BlackRock Fund Advisors has lifted its position by 27.33% or 0.11 million shares – to 0.51 million shares.
With over 0.16 million Gelesis Holdings Inc. (GLS) shares trading Tuesday and a closing price of $0.40 on the day, the dollar volume was approximately $62091.600000000006. The shares have shown a negative half year performance of -73.52% and its price on 01/24/23 gained nearly 11.81%. Currently, there are 72.77M common shares owned by the public and among those 34.73M shares have been available to trade.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
Insiders at the company have transacted a total of 28 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 28 of these insider trades were purchases, accounting for 3,256,386 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The top 3 mutual fund holders in Gelesis Holdings Inc. are Vanguard Total Stock Market Index, DNCA Invest – Beyond Global Leade, and Vanguard Extended Market Index Fu. Vanguard Total Stock Market Index owns 2.48 million shares of the company’s stock, all valued at over $0.72 million. Vanguard Extended Market Index Fu sold 447.0 shares to bring its total holdings to over 0.39 million shares at a value of $0.11 million. Vanguard Extended Market Index Fu now owns shares totaling to 0.54% of the shares outstanding.
However, the script later moved the day high at 0.4100, up 11.81%. The company’s stock has a 5-day price change of 8.78% and -21.09% over the past three months. GLS shares are trading 38.60% year to date (YTD), with the 12-month market performance down to -92.56% lower. It has a 12-month low price of $0.22 and touched a high of $6.76 over the same period. GLS has an average intraday trading volume of 154.81K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 13.53%, 15.12%, and -77.64% respectively.
Institutional ownership of Gelesis Holdings Inc. (NYSE: GLS) shares accounts for 37.50% of the company’s 72.77M shares outstanding. Mutual fund holders own 7.28%, while other institutional holders and individual stakeholders account for 8.97% and 6.81% respectively.
It has a market capitalization of $25.13M. The earnings-per-share (ttm) stands at -$10.86. Price movements for the stock have been influenced by the stock’s volatility, which stands at 15.14% over the week and 20.00% over the month.
Analysts forecast that Gelesis Holdings Inc. (GLS) will achieve an EPS of -$0.34 for the current quarter, -$0.3 for the next quarter and -$0.65 for 2023. The lowest estimate earnings-per-share for the quarter is -$0.34 while analysts give the company a high EPS estimate of -$0.34. Earnings per share for the fiscal year are expected to decrease by -396.40%, and 78.90% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 1 brokerage firm advisors rate Gelesis Holdings Inc. (GLS) as a “Hold” at a consensus score of 3.00. Specifically, 0 Wall Street analysts polled rate the stock as a buy, while 1 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”
